
There was no differences in serious adverse event rates between patients treated with the combination therapy and patients who withdrew from infliximab or immunosuppressant therapy.
Kenny Walter is an editor with HCPLive. Prior to joining MJH Life Sciences in 2019, he worked as a digital reporter covering nanotechnology, life sciences, material science and more with R&D Magazine. He graduated with a degree in journalism from Temple University in 2008 and began his career as a local reporter for a chain of weekly newspapers based on the Jersey shore. When not working, he enjoys going to the beach and enjoying the shore in the summer and watching North Carolina Tar Heel basketball in the winter.

There was no differences in serious adverse event rates between patients treated with the combination therapy and patients who withdrew from infliximab or immunosuppressant therapy.

Mattresses, toilet floors, and room floors were places where C difficile was commonly detected in areas inhabited by C difficile infection positive populations.

The guidelines include advocating for more preventative care and changing how the disease is diagnosed.

Dupilumab is currently the only treatment for eosinophilic esophagitis approved by the US Food and Drug Administration.

Nearly half of patients treated with vonoprazan 10 mg and 20 mg achieved more 24-hour heartburn free days compared to participants treated by placebo.

Gut microbiota diversity was lower in below average responders, while 39.5% of participants had a serological response below the geometric mean.

There was no significant differences in creatinine or estimated glomerular filtration rate between the readmission group and the no readmission group.

There have been more than 12,900 studies on the involvement of dysbiosis in the gensisinfectious diseases in the last 15 years.

The number needed to screen to detect unknown anti-HCV positive individual was 262 for those unaware of their infections.

The number of 30-day hospital readmissions because of CDI increased between 2010-2017.

Participants in the iPCIT group had significantly lower levels of externalizing problems and higher levels of compliance to caregiver direction compared to the referrals as usual group.

More patients are presenting with later stage liver cancer due to missed screenings during the COVID-19 pandemic.

The World Health Organization has set a goal of eradication for HCV by 2030.

Children definite motor problems were more likely to have psychotic experiences compared to children with no definite motor problems.

The prevalence of HBV among people who inject drugs was highest in East and Southeast Asia and lowest in Western Europe.

The FDA requested additional data showing the levels of a nitrosam impurity was below the set threshold throughout the life of vonoprazan.

Ulcerative colitis was considered an independent risk factor, while Crohn’s disease and unclassified inflammatory bowel disease were not.

Patients with late-onset depression died on average 1 year earlier than those with early-onset depression or those without late-life depression.

The topline phase 2b data shows both 75 mg and 150 mg doses of atacicept resulted in a 31% mean reduction in proteinuria.

Parenting stress, negative parenting practices, broken parental partnership, critical life events, parental psychopathologies, socioeconomic status, and single-parent family were all significantly associated with ADHD symptom severity.

The average hepatitis C virus incidence was 52% lower during the broad-DAA access period.

Previous trials using acupuncture in patients with irritable bowel syndrome have suffered from problems of high placebo response rates.

The results show similar rates o colonized C difficile among pediatric patients and adult patients with cystic fibrosis.

RBX2660 is the first ever live microbiota therapeutic approved by the FDA.

Pregnant individuals with opioid use disorder are commonly treated with methadone.

The results show patients with preclinical IBD had an increased in primary care visits up to 3-5 years prior to a diagnosis.

Neither finasteride nor dutasteride were linked to an increased risk of suicide.

In part A of the trial, 60% of patients treated with dupilumab weekly met the primary endpoint of histologic remission, compared to 5% of the placebo group.

There was a decrease in relapse observed for low-risk participants, but not high-risk individuals.

With the population aging, there is a need for new treatments in nephrology.